NCT02604550View on ClinicalTrials.gov

Anterior Cruciate Ligament Pain Study

PHASE4CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Anterior Cruciate Ligament Reconstruction
Interventions
DRUG

Ropivacaine 0.5%

Ropivacaine 0.5% will be administered to the femoral nerve or adductor canal.

DRUG

Percocet 7.5/325

Percocet 7.5/325 will taken as needed up to every four hours.

DRUG

Naprosyn 500 mg

Naprosyn 500 mg will be taken twice daily.

Trial Locations (1)

30329

Emory Healthcare Orthopaedics and Spine Center, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT02604550 - Anterior Cruciate Ligament Pain Study | Biotech Hunter | Biotech Hunter